Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech companies ranked by P/S ratio, at 3.8, followed by Qiagen (4.9) and Neurocrine Biosciences (5.8). Figures as of 19 Nov 2026, 00:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.8
Median
14.3
Combined market value
HUF 280.96T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
HUF
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.8HUF 12.48THUF 84,449.37 0.25% up 49% up United States
2QiagenQGEN · Health Care4.9HUF 3.44THUF 16,647.35 0.38% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.8HUF 5.54THUF 54,705.16 1.84% down 20% up United States
4BioNTechBNTX · Health Care6.5HUF 6.93THUF 27,967.28 1.89% down 16% down Germany
5AmgenAMGN · Health Care6.5HUF 80.65THUF 149,103.98 3.07% down 34% up United States
6Gilead SciencesGILD · Health Care7.1HUF 70.4THUF 56,760.89 0.75% down 33% up United States
7ExelixisEXEL · Health Care7.2HUF 5.6THUF 22,938.82 0.31% down 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.8HUF 3.67THUF 32,179.51 0.18% down 37% up United States
9Bio-TechneTECH · Health Care9.4HUF 3.84THUF 24,436.94 0.17% up 26% up United States
10argenxARGX · Health Care14.3HUF 19.88THUF 316,168.70 0.66% down 4% up Belgium
11RepligenRGEN · Health Care15.0HUF 3.71THUF 58,000.37 6.47% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.6HUF 1.55THUF 9,559.80 0.11% down 88% up United States
13Twist BioscienceTWST · Health Care21.1HUF 2.66THUF 39,082.31 3.88% up 340% up United States
14Krystal BiotechKRYS · Health Care24.0HUF 3.14THUF 105,923.65 5.62% up 46% up United States
15ModernaMRNA · Health Care41.0HUF 26.75THUF 66,102.35 4.84% down 755% up United States
16ImmunityBioIBRX · Health Care62.9HUF 2.39THUF 2,250.55 7.03% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care264HUF 3.47THUF 40,687.93 0.32% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1111HUF 1.31THUF 13,499.94 0.10% up 21% down Switzerland
19CG OncologyCGON · Health Care1769HUF 2.4THUF 26,872.24 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 335.9 HUF). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/S ratio?

Biogen (3.8), Qiagen (4.9) and Neurocrine Biosciences (5.8) have the lowest P/S ratio of the 19 biotech companies ranked here as of 19 Nov 2026, 00:16 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of HUF 280.96T as of 19 Nov 2026, 00:16 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.